A desferrioxamine B squaramide ester for the incorporation of zirconium-89 into antibodies.
Chem Commun (Camb)
; 52(80): 11889-11892, 2016 Sep 29.
Article
en En
| MEDLINE
| ID: mdl-27711378
A squaramide ester derivative of desferrioxamine B (H3DFO) that is compatible with aqueous solvents and does not induce antibody aggregation is used to attach the siderophore to the antibody trastuzumab. The new conjugates were radiolabeled with zirconium-89 to give complexes that are more resistant to ligand exchange when compared to currently used H3DFO derivatives and result in high quality positron emission tomography images in mouse models of HER2 positive breast cancer.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Deferoxamina
/
Anticuerpos Monoclonales Humanizados
/
Trastuzumab
Tipo de estudio:
Diagnostic_studies
/
Prognostic_studies
Límite:
Animals
/
Female
/
Humans
Idioma:
En
Revista:
Chem Commun (Camb)
Asunto de la revista:
QUIMICA
Año:
2016
Tipo del documento:
Article
País de afiliación:
Australia
Pais de publicación:
Reino Unido